CytRx (CYTR) Aims to Accelerate Enrollment in Tamibarotene Phase 2b with Site Expansion
Tweet Send to a Friend
CytRx Corporation (Nasdaq: CYTR) reports that it has expanded enrollment to 15 clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
